Data di Pubblicazione:
2023
Citazione:
Pericardial Diseases in Pregnancy / Serati, L; Mardigyan, V; Dominioni, Cc; Agozzino, F; Bizzi, E; Trotta, L; Nivuori, M; Maestroni, S; Negro, E; Imazio, M; Brucato, A. - In: CANADIAN JOURNAL OF CARDIOLOGY. - ISSN 0828-282X. - 39:8(2023), pp. 1067-1077. [10.1016/j.cjca.2023.04.010]
Abstract:
Pericardial effusion is the most common manifestation of pericardial diseases during pregnancy. This effusion is benign, mild, or moderate, well tolerated, with spontaneous resolution after delivery; no specific treatment is required. Acute pericarditis is the second most common condition, usually requiring medical therapy during pregnancy. Cardiac tamponade and constrictive pericarditis are rare in pregnancy. Pre-pregnancy counselling is essential in women of childbearing age with recurrent pericarditis to plan pregnancy in a phase of disease quiescence and to review therapy. High-dose aspirin or nonselective nonsteroidal anti-inflammatory drugs, such as ibuprofen and indomethacin, can be used up to the 20th week of gestation. Low-dose prednisone (2.5-10 mg/d) can be administered throughout pregnancy. All of these medications, apart from high-dose aspirin, may be used during lactation. Colchicine is compatible with pregnancy and breastfeeding, and it can be continued throughout pregnancy to prevent recurrences. Appropriate follow-up with a multidisciplinary team with experience in the field is recommended throughout pregnancy to ensure good maternal and fetal outcomes.
Tipologia CRIS:
1.1.1 Articolo in rivista - Review
Elenco autori:
Serati, L; Mardigyan, V; Dominioni, Cc; Agozzino, F; Bizzi, E; Trotta, L; Nivuori, M; Maestroni, S; Negro, E; Imazio, M; Brucato, A
Link alla scheda completa:
Pubblicato in: